ArticleNPJ digital medicine2026
Roadmap of remote photoplethysmography from heart rate measurement toward clinical translation.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lighting effects on optimal facial regions for remote heart rate measurement.NPJ cardiovascular health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Remote photoplethysmography (rPPG) enables non-contact heart rate (HR) and waveform measurement from facial video, offering advantages over contact methods while contending with motion, illumination changes, compression, and frame-rate variability. This roadmap integrates a systematic review, technical synthesis, and a clinic-acquired demonstration to accelerate rPPG research and translation. We outline the measurement pipeline and synthesize progress across eight domains: datasets, device factors, data scarcity, skin/ROI detection, model- and data-driven algorithms, filtering, and evaluation metrics. Strategies for improved robustness include targeted dataset expansion, augmentation, optimized ROI policies, motion and photometric normalization, and hardware configuration. A proof-of-feasibility using data collected in a routine clinical setting alongside reference monitors demonstrates high signal-level agreement under a multi-metric framework (correlation/concordance, absolute errors, and Bland-Altman bias/dispersion). We conclude with recommendations for accuracy, efficiency, and deployment in real-world and clinical contexts, providing a consolidated resource for researchers and clinicians and a pragmatic path toward reliable clinical adoption.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.